Target intelligence / Profile preview

Coagulation system (Coagulation cascade)

Molecular classification
Enzyme system (composed of serine proteases and co-factors), Plasma protein complex, Other
01

Overview

The **coagulation system**, often referred to as the **coagulation cascade**, is a complex series of enzymatic reactions involving plasma proteins (mainly serine proteases, cofactors, and glycoproteins) that control blood clotting to achieve hemostasis[1][2][4][3][5]. The process is initiated by either the tissue factor (extrinsic) pathway or the contact activation (intrinsic) pathway, both converging on the common pathway leading to activation of factor X, formation of thrombin, and conversion of fibrinogen to insoluble fibrin, which forms the clot structure[1][3][4]. This cascade is tightly regulated to prevent both excessive bleeding and abnormal clot formation, and disturbances contribute to a wide range of bleeding and thrombotic diseases[2][4][3].

Other names
coagulation cascadeblood coagulationcoagulation pathwayblood clotting pathway
02

Mechanism of action

Inhibition of specific coagulation factors to prevent clot formation (e.g., warfarin inhibits vitamin K-dependent factors); Direct inhibition of thrombin or factor Xa (e.g., direct oral anticoagulants); Activation of fibrinolysis to dissolve clots (e.g., tPA increases conversion of plasminogen to plasmin); Factor replacement to restore deficient factors in hemophilia.

03

Biological functions

Hemostasis (cessation of bleeding)Blood clot formationRegulation of fibrinolysisWound healingInflammatory response
04

Disease associations

Thrombosis (pathological clot formation)Hemophilia and other bleeding disordersDisseminated intravascular coagulationCardiovascular diseases (e.g., stroke, myocardial infarction)Sepsis-related coagulopathy
05

Safety considerations

Risk of bleeding (hemorrhage) with anticoagulants and fibrinolyticsRisk of thrombosis (clotting disorders) with insufficient anticoagulation or in hypercoagulable statesDisseminated intravascular coagulation (uncontrolled activation)Heparin-induced thrombocytopenia
06

Interacting drugs

Warfarin

7 more in the full profile.

07

Biomarkers

D-dimer (fibrin degradation product)Prothrombin time (PT)Activated partial thromboplastin time (aPTT)Fibrinogen levelsPlatelet countSpecific factor assays (e.g., factor VIII, IX activity)

Beyond the preview

Go deeper on Coagulation system (Coagulation cascade).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coagulation system (Coagulation cascade).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call